News
Press Releases & Media
Latest updates from Carvolix and our portfolio companies.
Carvolix is born and funded
Press Release
Carvolix is born and funded
- Affluent Medical officially becomes CARVOLIX
- Completion of the acquisitions of CARANX MEDICAL and ARTEDRONE
- 10m€ first tranche of financing completed
February 2026
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
Press Release
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
December 2025
Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
Press Release
Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
December 2025
Carvolix appoints Liane Teplitsky as a new member of the Board of Directors
Press Release
Carvolix appoints Liane Teplitsky as a new member of the Board of Directors
April 2025